Hematopoietic Cell Transplantation
Recorded on: June 24, 2024
Recorded on: June 24, 2024
Estimated Time to Complete: 2.15 hours
2.15 CE Credits/Contact hours for nurses and social workers available until: November 24, 2026
Format: Non-interactive recorded webinar
Target Audience
Oncology nurse practitioners, nurses, and social workers involved in the care of patients with hematopoietic cell transplantation (HCT).
Course content level for social workers: all levels
Description
This program covers the types of hematopoietic cell transplantation (HCT) used in the treatment of blood cancers, how donor type, graft source, and conditioning intensity are chosen, overarching goals of HCT, and strategies to manage treatment side effects and long-term and late effects. The goal of this program is to focus on the team approach and help participants gain knowledge of HCT complexities, and resources for educating and supporting patients, to foster improved patient outcomes.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the types of HCT on used in the treatment of blood cancers, including autologous, allogeneic and reduced-intensity allogeneic stem cell transplantation
- Identify the methods of stem cell collection used in patients with blood cancers
- Explain the overarching goals of HCT for all types of blood cancers
- Explain HCT as a treatment option for blood cancers
- Describe strategies to manage treatment side effects as well as potential long-term and late effects of HCT
- Describe the healthcare professional’s role in managing patients with HCT
Faculty
Ran Reshef, MD MSc
Professor of Medicine
Deputy Director
Blood and Marrow Transplantation and Cell Therapy Program
Division of Hematology/Oncology
Columbia University Irving Medical Center
Columbia University Vagelos College of Physicians & Surgeons
New York, NY
David Sabatino, PharmD, BCOP
Clinical Pharmacy Manager
Stem Cell Transplant/ Myeloma
NewYork-Presbyterian Hospital
Columbia University Irving Medical Center
New York, NY
Tricia Skvarce, MSHS, PA-C
Supervisor Physician Assistant
Blood and Marrow Transplant
New York Presbyterian Hospital
Columbia University Irving Medical Center
New York, NY
Muyun Zhao, LMSW
Social Worker
BMT Program at New York Presbyterian Hospital
Columbia University Irving Medical Center
New York, NY
Continuing Education Information
Nursing Continuing Professional Development
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 2.15 continuing education contact hours through the California Board of Registered Nursing.
Social Worker Continuing Education
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 2.15 clinical continuing education credits.
The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 2.15 clinical CE contact hours for this activity.
Nurse Practitioner Continuing Education
This education activity will be submitted to the American Association of Nurse Practitioners® for approval of up to 2.15 contact hours of accredited education.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest, evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit.
If you have questions regarding your certificate, please contact Nicole Dane via email at ndane@kimeglobal.com.
Providers
This activity is provided by The Leukemia & Lymphoma Society.
Supporters
There is no commercial support associated with this CE activity.
Participants gain access to the webinar via the participation button above.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org.